Hayashi Hiroki, Nei Takahito, Abe Shinji, Saito Yoshinobu, Kokuho Nariaki, Atsumi Kenichiro, Fujita Kazue, Saito Takefumi, Tanaka Takahiro, Gemma Akihiko, Azuma Arata
Department of Respiratory Medicine, Nippon Medical School.
Department of Respiratory Medicine, National Hospital Organization, Ibarakihigashi National Hospital.
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):35-40. doi: 10.36141/svdld.v34i1.5172. Epub 2017 Apr 28.
Idiopathic pleuroparenchymal fibroelastosis (IPPFE) was recently proposed as an entity to be included among rare idiopathic interstitial pneumonias (IIPs). However, the cause, clinical features and prognosis of this rare entity have not been elucidated. We aimed to examine the clinical features, outcomes and prognostic factors for IPPFE in comparison to those of idiopathic pulmonary fibrosis (IPF). We retrospectively analyzed 20 patients with IPPFE and 71 with IPF. We compared clinical features, blood examination data, and respiratory functions at the time of diagnosis. The IPPFE group had a significantly lower body mass index (BMI), percent forced vital capacity (%FVC), total lung capacity (%TLC) and expiratory reserve volume (%ERV), as well as a higher residual volume to TLC (RV/TLC) ratio than the IPF group. The annual FVC changes in the IPPFE group (-326ml/year) were significantly larger than those in the IPF group (-142ml/year). Survival was significantly poorer in the IPPFE than in the IPF group ( = 0.021). BMI and the partial pressure of oxygen in arterial blood (PaO) were significantly related to the outcome of IPPFE. Our present results indicate the prognosis of IPPFE patients to be poorer than that of IPF patients. We advocate that BMI and arterial blood PaO be determined at the first visit as these parameters are closely related to patients' outcomes. Prospective evaluation of IPPFE starting in the subclinical phase is necessary to assure that appropriate measures are taken before progression. .
特发性胸膜肺实质纤维弹性组织增生症(IPPFE)最近被提议作为一种罕见的特发性间质性肺炎(IIP)纳入其中。然而,这种罕见疾病的病因、临床特征和预后尚未阐明。我们旨在比较IPPFE与特发性肺纤维化(IPF)的临床特征、结局和预后因素。我们回顾性分析了20例IPPFE患者和71例IPF患者。我们比较了诊断时的临床特征、血液检查数据和呼吸功能。与IPF组相比,IPPFE组的体重指数(BMI)、用力肺活量百分比(%FVC)、肺总量百分比(%TLC)和呼气储备量百分比(%ERV)显著更低,残气量与肺总量(RV/TLC)比值更高。IPPFE组的年FVC变化(-326ml/年)显著大于IPF组(-142ml/年)。IPPFE组的生存率显著低于IPF组(P = 0.021)。BMI和动脉血氧分压(PaO)与IPPFE的结局显著相关。我们目前的结果表明,IPPFE患者的预后比IPF患者差。我们主张在首次就诊时测定BMI和动脉血PaO,因为这些参数与患者的结局密切相关。有必要对亚临床期开始的IPPFE进行前瞻性评估,以确保在病情进展前采取适当措施。